Kirk Dobbins and Kurt Karst to Speak at ACI Conference


June 5, 2007

Maximizing Pharmaceutical Patent Life Cycles

The definitive Hatch-Waxman event for biopharmas, brand names and generics

InterContinental Mark Hopkins Hotel

San Francisco, CA

Kirk Dobbins will be presenting:

   New Pre-Commercialization Concerns for Small Molecules and Biologics

Kurt Karst will be presenting:

   Drugs and Biologics: The Nature of the Approval Process

   Present Controversies and Uncertainties in Market Exclusivity